Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise A Galloway

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Cell Host & Microbe|June 10, 2016
The Murky Life of Merkel Cell PolyomavirusDenise A Galloway
Genes & Development|January 28, 2009
Human papillomaviruses: a growing fieldDenise A Galloway
The Lancet. Infectious Diseases|August 7, 2003
Papillomavirus vaccines in clinical trialsDenise A Galloway
Plos Pathogens|March 1, 2019
High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2Sujita Khanal, Denise A Galloway
Current Opinion in Virology|September 24, 2015
Human papillomaviruses: shared and distinct pathways for pathogenesisDenise A Galloway, Laimonis A Laimins
Cell Host & Microbe|September 14, 2010
Stopping HPVs dead in their tractsJoseph J Carter, Denise A Galloway
Carcinogenesis|February 14, 2003
Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteinsAnna-Marija Helt, Denise A Galloway
Molecular and Cellular Biology|March 17, 2004
Normal human fibroblasts are resistant to RAS-induced senescenceJennifer A Benanti, Denise A Galloway
Annual Review of Virology|March 10, 2016
Novel Functions of the Human Papillomavirus E6 OncoproteinsNicholas A Wallace, Denise A Galloway
Cell Cycle (Georgetown, Tex.)|May 22, 2004
The normal response to RAS: senescence or transformation?Jennifer A Benanti, Denise A Galloway
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Cell Host & Microbe|June 10, 2016
The Murky Life of Merkel Cell PolyomavirusDenise A Galloway
Genes & Development|January 28, 2009
Human papillomaviruses: a growing fieldDenise A Galloway
The Lancet. Infectious Diseases|August 7, 2003
Papillomavirus vaccines in clinical trialsDenise A Galloway
Plos Pathogens|March 1, 2019
High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2Sujita Khanal, Denise A Galloway
Current Opinion in Virology|September 24, 2015
Human papillomaviruses: shared and distinct pathways for pathogenesisDenise A Galloway, Laimonis A Laimins
Cell Host & Microbe|September 14, 2010
Stopping HPVs dead in their tractsJoseph J Carter, Denise A Galloway
Carcinogenesis|February 14, 2003
Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteinsAnna-Marija Helt, Denise A Galloway
Molecular and Cellular Biology|March 17, 2004
Normal human fibroblasts are resistant to RAS-induced senescenceJennifer A Benanti, Denise A Galloway
Annual Review of Virology|March 10, 2016
Novel Functions of the Human Papillomavirus E6 OncoproteinsNicholas A Wallace, Denise A Galloway
Cell Cycle (Georgetown, Tex.)|May 22, 2004
The normal response to RAS: senescence or transformation?Jennifer A Benanti, Denise A Galloway
Pageof 13